Page last updated: 2024-10-17

guaiacol and Fatty Liver, Nonalcoholic

guaiacol has been researched along with Fatty Liver, Nonalcoholic in 4 studies

Guaiacol: An agent thought to have disinfectant properties and used as an expectorant. (From Martindale, The Extra Pharmacopoeia, 30th ed, p747)
methylcatechol : Any member of the class of catechols carrying one or more methyl substituents.
guaiacol : A monomethoxybenzene that consists of phenol with a methoxy substituent at the ortho position.

Research Excerpts

ExcerptRelevanceReference
"This study was conducted to test the protective potential of Zingerone against a high-fat diet (HFD)-mediated non-alcoholic fatty liver disease (NAFLD) development in rats and examined in this protection is mediated modulating AMP-activated protein kinase (AMPK)."8.12Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK. ( Mohammed, HM, 2022)
"NAFLD is currently one of the most common etiologies of chronic liver disease worldwide."5.43Hepatoprotective potential of zingerone against nonalcoholic fatty liver disease in rats fed with fructose-enriched diet. ( Jesudoss, VA; Muniandy Narayanan, J, 2016)
"This study was conducted to test the protective potential of Zingerone against a high-fat diet (HFD)-mediated non-alcoholic fatty liver disease (NAFLD) development in rats and examined in this protection is mediated modulating AMP-activated protein kinase (AMPK)."4.12Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK. ( Mohammed, HM, 2022)
"NAFLD is currently one of the most common etiologies of chronic liver disease worldwide."1.43Hepatoprotective potential of zingerone against nonalcoholic fatty liver disease in rats fed with fructose-enriched diet. ( Jesudoss, VA; Muniandy Narayanan, J, 2016)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Mohammed, HM1
Sim, WC1
Park, S1
Lee, KY1
Je, YT1
Yin, HQ1
Choi, YJ1
Sung, SH1
Park, SJ1
Park, HJ1
Shin, KJ1
Lee, BH1
Muniandy Narayanan, J1
Jesudoss, VA1
Lee, MS1
Kim, KJ1
Kim, D1
Lee, KE1
Hwang, JK1

Other Studies

4 other studies available for guaiacol and Fatty Liver, Nonalcoholic

ArticleYear
Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK.
    Journal of food biochemistry, 2022, Volume: 46, Issue:7

    Topics: AMP-Activated Protein Kinases; Animals; Guaiacol; NF-E2-Related Factor 2; NF-kappa B; Non-alcoholic

2022
LXR-α antagonist meso-dihydroguaiaretic acid attenuates high-fat diet-induced nonalcoholic fatty liver.
    Biochemical pharmacology, 2014, Aug-15, Volume: 90, Issue:4

    Topics: Animals; Base Sequence; Cell Line, Tumor; Diet, High-Fat; DNA Primers; Fatty Liver; Guaiacol; Humans

2014
Hepatoprotective potential of zingerone against nonalcoholic fatty liver disease in rats fed with fructose-enriched diet.
    General physiology and biophysics, 2016, Volume: 35, Issue:2

    Topics: Animals; Antioxidants; Dietary Sucrose; Fructose; Guaiacol; Lipid Metabolism; Liver; Male; Non-alcoh

2016
meso-Dihydroguaiaretic acid inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in human HepG2 cells.
    Biological & pharmaceutical bulletin, 2011, Volume: 34, Issue:10

    Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Cell Culture Techniques; Dose-Response Relati

2011